Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 7, 2008, Pages 363-366

  Jiang, Xin ^a   Wang, Na ^b   Zhang, Zun Jian ^b   Tian, Yuan ^b   Chen, Yun ^c  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Antifungal; CAS 91161 71 6; Terbinafine, bioequivalence, pharmacokinetics

Indexed keywords

TERBINAFINE;

ADULT; ARTICLE; BIOEQUIVALENCE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SPECTROPHOTOMETER;

EID: 49449117152     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296521     Document Type: Article

References (6)

1. Zehende H, Denouël J, Roy M, Le Saux P. Schaub. Simultaneous determination of terbinafine (Lamisil) and five metabolites in human plasma and urine by high-performance liquid chromatography using on-line solid-phase extraction. J Chromatogr B. 1995;664:347-355.
2. Denouël J, Keller HR Schaub P, Delaborde C, Humbert H. Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatography. J Chromatogr B. 1995;663:352-359.
3. Lamisil-Clinical Pharmacology, http://www.rxlist.com/cgi/generic/ terbin_cp.htm.
4. Leyden JM. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol. 1998;38: S42-47.
5. US Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation. 2001.
6. Almeida S, Filipe A, Vallée F, Tanguay M, Larouche R, Lainesse A. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers. Arzneimittel-Forschung (Drug Research). 2004;54:757-762.